Compare Vir Biotechnology Inc. Common Stock (VIR) vs Veralto Corp Common Stock (VLTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vir Biotechnology Inc. Common Stock vs Veralto Corp Common Stock — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B), while Veralto Corp Common Stock trades at $101.5 (market cap $24.13B). The key difference: Veralto Corp Common Stock is far larger — about 13.4× Vir Biotechnology Inc. Common Stock's market cap, and Veralto Corp Common Stock pays a 0.53% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and Veralto Corp Common Stock for 0 Days on average.
| VIR | VLTO | |
|---|---|---|
Market Cap | $1.80B | $24.13B |
Volume | 1,782,836 | 1,906,414 |
Sector | Health | Industrials |
52-Week High | $11.78 | $104.87 |
52-Week Low | $5.12 | $82.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.36B | $25.39B |
Dividend Yield | — | 0.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →About Veralto Corp Common Stock
Veralto Corporation provides water quality and product quality technologies through two segments, Water Quality and Product Quality & Innovation. Its offerings include water analytics and treatment instruments, marking and coding equipment for packaging, and color measurement solutions such as X-Rite.
Read more on VLTO →
